Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

: ComparatorDefinition: Glucagon-Like Peptide-1 (GLP-1) receptor agonists - JSON Representation

Raw json | Download

{
  "resourceType" : "Group",
  "id" : "236776",
  "meta" : {
    "versionId" : "63",
    "lastUpdated" : "2024-12-14T08:46:28.847Z",
    "profile" : [
      🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-definition"
    ]
  },
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Group 236776</b></p><a name=\"236776\"> </a><a name=\"hc236776\"> </a><a name=\"236776-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">version: 63; Last updated: 2024-12-14 08:46:28+0000</p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-exposure-definition.html\">ExposureDefinition</a></p></div><p><b>Artifact Author</b>: Computable Publishing®: MAGIC-to-FEvIR Converter: </p><p><b>Artifact related artifact</b>: No display for RelatedArtifact  (type: part-of; resourceReference: -&gt;display: string (PrimitiveType/Group.extension[1].value[x].resourceReference.display): element = string -&gt; display=string[MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes])</p><p><b>url</b>: <a href=\"https://fevir.net/resources/Group/236776\">https://fevir.net/resources/Group/236776</a></p><p><b>identifier</b>: FEvIR Object Identifier/https://fevir.net/FOI/236776, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-comparator-85394-C-85798</p><p><b>name</b>: Glucagon_Like_Peptide_1_GLP_1_receptor_agonists85394_C_85798</p><p><b>title</b>: ComparatorDefinition: Glucagon-Like Peptide-1 (GLP-1) receptor agonists</p><p><b>status</b>: Active</p><p><b>publisher</b>: Computable Publishing LLC</p><p><b>contact</b>: <a href=\"mailto:support@computablepublishing.com\">support@computablepublishing.com</a></p><p><b>description</b>: </p><div><p>This Group Resource is referenced in an example for the EBMonFHIR Implementation Guide.</p>\n</div><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication</a>: Evidence Communication</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ExposureDefinition}\">ExposureDefinition</span></td></tr></table><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>\n</div><p><b>membership</b>: Conceptual</p></div>"
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/artifact-author",
      "valueContactDetail" : {
        "name" : "Computable Publishing®: MAGIC-to-FEvIR Converter"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact",
      "valueRelatedArtifact" : {
        "type" : "part-of",
        "resourceReference" : {
          "type" : "Composition",
          "identifier" : {
            "type" : {
              "text" : "FEvIR Linking Identifier"
            },
            "system" : "https://fevir.net/FLI",
            "value" : "MAGIC-5288-j1Wqrn-conversion-report",
            "assigner" : {
              "display" : "Computable Publishing LLC"
            }
          },
          "display" : "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes"
        }
      }
    }
  ],
  "url" : "https://fevir.net/resources/Group/236776",
  "identifier" : [
    {
      "type" : {
        "coding" : [
          {
            "system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code" : "ACSN",
            "display" : "Accession ID"
          }
        ],
        "text" : "FEvIR Object Identifier"
      },
      "system" : "urn:ietf:rfc:3986",
      "value" : "https://fevir.net/FOI/236776",
      "assigner" : {
        "display" : "Computable Publishing LLC"
      }
    },
    {
      "type" : {
        "text" : "FEvIR Linking Identifier"
      },
      "system" : "https://fevir.net/FLI",
      "value" : "MAGIC-5288-j1Wqrn-comparator-85394-C-85798",
      "assigner" : {
        "display" : "Computable Publishing LLC"
      }
    }
  ],
  "name" : "Glucagon_Like_Peptide_1_GLP_1_receptor_agonists85394_C_85798",
  "title" : "ComparatorDefinition: Glucagon-Like Peptide-1 (GLP-1) receptor agonists",
  "status" : "active",
  "publisher" : "Computable Publishing LLC",
  "contact" : [
    {
      "telecom" : [
        {
          "system" : "email",
          "value" : "support@computablepublishing.com"
        }
      ]
    }
  ],
  "description" : "This Group Resource is referenced in an example for the EBMonFHIR Implementation Guide.",
  "useContext" : [
    {
      "code" : {
        "system" : "https://fevir.net/resources/CodeSystem/179423",
        "code" : "evidence-communication",
        "display" : "Evidence Communication"
      },
      "valueCodeableConcept" : {
        "coding" : [
          {
            "system" : "https://fevir.net/resources/CodeSystem/179423",
            "code" : "ExposureDefinition",
            "display" : "ExposureDefinition"
          }
        ]
      }
    }
  ],
  "copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
  "membership" : "conceptual"
}